Skip to content
  • Diet & Nutrition
  • Lifestyle & Wellbeing
  • News & Research
  • Treatment & Management
  • Patient Narratives
  • Glycaemic Index
  • Carbohydrate Counting
Quest Diabetes
Quest Diabetes
  • Diet & Nutrition
  • Lifestyle & Wellbeing
  • News & Research
  • Treatment & Management
  • Patient Narratives
  • Glycaemic Index
  • Carbohydrate Counting
Quest Diabetes
  • News & Research

UK becomes first in Europe to approve oral GLP-1 weight-loss medication for adults with obesity and type 2 diabetes

The UK has approved orforglipron, a new once-daily oral medication for weight management and type 2 diabetes, marking a first in Europe. The drug offers a convenient alternative to existing treatments and is subject to NHS evaluation before wider availability.…

  • apxadmin
  • August 10, 2026
  • Treatment & Management

First GLP-1 tablet for weight management approved in the UK disrupts obesity treatment options

Scotland-based health regulators have authorised orforglipron, a first-of-its-kind daily GLP-1 tablet, promising new options for adults with obesity and type 2 diabetes in the UK, subject to further NHS evaluation. Scotland-based health regulators have authorised a new daily weight-loss tablet…

  • apxadmin
  • August 10, 2026
  • Carbohydrate Counting

Understanding blood sugar responses: moderation and meal composition matter more than eliminating carbs

New insights highlight that managing blood sugar levels involves focusing on portion sizes and meal composition, rather than banning all sugars or starches, with experts emphasizing moderation and understanding different carbohydrate types. For people watching blood sugar, the issue is…

  • apxadmin
  • August 10, 2026
  • News & Research

Medtech industry faces reshaping as tariffs, inflation, and geopolitical tensions accelerate supply chain disruptions

Rising tariffs, inflation, and geopolitical tensions are forcing the medical technology sector to re-evaluate production and distribution models, particularly for diabetes devices, amid increasing industry resilience efforts. GlobalData Healthcare says tariffs, inflation and shifting geopolitical tensions are placing fresh strain…

  • apxadmin
  • August 10, 2026
  • News & Research

Quercetin’s potential in metabolic health faces hurdles despite promising mechanisms

While laboratory studies highlight quercetin’s multi-faceted influence on insulin pathways, inflammation, and gut health, clinical evidence remains inconsistent, underscoring challenges in translating its promise into effective treatments. Quercetin has emerged as one of the more closely watched plant compounds in…

  • apxadmin
  • August 10, 2026
  • News & Research

Study reinforces link between gum disease and increased risk of type 2 diabetes

A comprehensive review of over 300,000 individuals across 16 countries underscores the strong association between severe gum disease and future diabetes risk, highlighting the importance of integrating dental and medical care. A recent systematic review has added weight to the…

  • apxadmin
  • August 10, 2026
  • Diet & Nutrition

Reinventing ratatouille: versatile, diabetes-friendly vegetable stew gains modern twists

A timeless Provençal vegetable dish is being adapted into a flexible, health-conscious meal scheme, offering new varieties that prioritise flavour, fibre, and protein for those managing diabetes. Ratatouille, the Provençal vegetable stew, makes an easy lunchtime option for people looking…

  • apxadmin
  • August 10, 2026
  • Glycaemic Index

The deceptive marketing behind the “Glucose Reset Ritual” and its imitators

Repeated rebrandings and aggressive sales tactics characterise the “Glucose Reset Ritual” scams, which exploit authoritative appearances and false endorsements to deceive consumers into buying ineffective blood-sugar supplements with potentially harmful consequences. The “Glucose Reset Ritual” is less a single product…

  • apxadmin
  • August 10, 2026
  • Patient Narratives

The glucose reset ritual: a recycled scam masking as health innovation

A widespread marketing tactic attaches the ‘Glucose Reset Ritual’ to various blood-sugar supplements, employing fake endorsements and shifting brand names, raising concerns over consumer deception and safety. The “Glucose Reset Ritual” is not a single product so much as a…

  • apxadmin
  • August 10, 2026
  • Treatment & Management

Glyco Harmony Drops questioned as misleading marketing tactics surface in blood sugar scam

Investigations reveal that Glyco Harmony Drops, marketed as a natural blood sugar aid, employs misleading claims and aggressive sales tactics without credible scientific backing, raising concerns over consumer vulnerability and safety. Glyco Harmony Drops is being pitched as a natural…

  • apxadmin
  • August 10, 2026
Prev
1 … 204 205 206 207 208 209 210 … 229
Next

Search

No results

Posts

Old mathematical tools find new relevance in biomedical research

September 13, 2026

Austria’s 2024 dietary guidelines spotlight legumes’ evolving health and environmental roles

September 14, 2026

Why green and ripe plantains can affect blood sugar differently

October 23, 2026

Why cutting sweets alone may not keep blood sugar under control

October 29, 2026

Why people with diabetes should count pumpkin as a carb

October 16, 2026

Trending now

New guidelines help people with diabetes enjoy summer cookouts without guilt
Gestational diabetes alters early brain response to food cues during pregnancy
Personal glucose pattern analyser offers targeted insights for diabetes management
Early blood-flow checks urged to help prevent diabetic foot amputations

Copyright © 2026 - QuestDiabetes.com

Disclaimer | Terms & Conditions | Privacy Policy